Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2017

01-03-2017 | Letter to the Editor

Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case

Authors: Khaoula Ben Younes, Raoudha Doghri, Karima Mrad, Neila Ben Romdhane, Fatma Ben Aissa-Fennira

Published in: Annals of Hematology | Issue 3/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Swerdlow SH, Campo E, Harris NL et al (2008) World Health Organization Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer (IARC) Press, Lyon
2.
Shimizu-Kohno K, Kimura Y, Kiyasu J et al (2012) Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases. Pathol Int 62(9):577–582CrossRefPubMed
3.
Mollejo M, Algara P, Mateo MS et al (2002) Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma. Histopathology 40(1):22–30CrossRefPubMed
4.
Kalaszczynska I, Geng Y, Iino T et al (2009) Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 138(2):352–365CrossRefPubMedPubMedCentral
5.
Chao Y, Shih YL, Chiu JH et al (1998) Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 58(5):985–990PubMed
6.
Mrena J, Wiksten JP, Kokkola A, Nordling S, Haglund C, Ristimäki A (2006) Prognostic significance of cyclin A in gastric cancer. Int J Cancer 119(8):1897–1901CrossRefPubMed
7.
Paterlini P, Suberville AM, Zindy F et al (1993) Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 53(2):235–238PubMed
8.
Wang LH, Huang W, Lai MD, Su IJ (2012) Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis 33(2):466–472CrossRefPubMed
9.
Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma V-M (1999) Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 80(12):2001–2007CrossRefPubMedPubMedCentral
10.
Aaltomaa S, Eskelinen M, Lipponen P (1999) Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival. Prostate 38(3):175–182CrossRefPubMed
Metadata
Title
Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case
Authors
Khaoula Ben Younes
Raoudha Doghri
Karima Mrad
Neila Ben Romdhane
Fatma Ben Aissa-Fennira
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2860-2

Other articles of this Issue 3/2017

Annals of Hematology 3/2017 Go to the issue

Letter to the Editor

Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence

Original Article

BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients

Letter to the Editor

Cold agglutinin disease complicated by acrocyanosis and necrosis

Original Article

Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML

Letter to the Editor

Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

Letter to the Editor

Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits